Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Eniola Odetunde/Axios

The massive disruption caused by COVID-19 could lead companies to tap automation to manufacture products much closer to home.

Why it matters: The pandemic is revealing that the globalized supply chain that brings us many of our products is shockingly fragile. Easily programmable industrial robots could make it simpler to produce what we use here in the U.S., reducing that vulnerability.

Even before the novel coronavirus reached the U.S., the supply chain disruptions caused by the virus' spread in China were damaging the American economy.

  • On Feb. 17, when there were just 15 confirmed cases of COVID-19 in the U.S., Apple issued an earnings warning because of the impact of the virus on its Chinese suppliers.
  • China made half the world's respiratory masks before COVID-19 hit and restricted exports once the pandemic was in full force, leaving other countries, including the U.S., with dwindling supplies.

Context: Obviously, the U.S. needs stronger domestic manufacturing capability, especially right now. But it's not just that American companies have grown dependent on international supply chains.

  • As of last fall, U.S. manufacturers reported more than 500,000 unfilled jobs, due in large part to a gap between the skills companies needed and the skills workers had.

If workers aren't available, one option might be robots.

  • Ready Robotics, a startup spun out of Johns Hopkins University, provides simple software to power industrial robots. The software allows workers with little to no experience in robotics to program industrial robots for manufacturing work.
  • With robots that are more easily customizable, manufacturers can employ them for short and custom runs, mixing up what they can produce. "If you do it today, it takes 4 to 8 weeks of setup time," says Ben Gibbs, Ready Robotics CEO. "With our software, it's 4 to 8 hours for a run."

These changes were already underway before the pandemic, but COVID-19 may accelerate them.

  • "The future of supply chain infrastructure will be focused on improving resiliency through onshoring and automation," says Rayfe Gaspar-Asaoka, a venture capitalist at Canaan. "It's the Zoom + Slack of manufacturing."

The bottom line: The first response in a pandemic is to stick close to home. That may prove true for manufacturing as well.

Go deeper...Report: Drop in medical supplies tied to decreased China imports as coronavirus spreads

Go deeper

56 mins ago - Health

WHO: AstraZeneca vaccine must be evaluated on "more than a press release"

A medical syringe and vial with fake coronavirus vaccine in front of the World Health Organization (WHO) logo. Photo Illustration: Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

Top scientists at the World Health Organization on Friday called for more detailed information on a coronavirus vaccine developed by AstraZeneca and the University of Oxford.

Why it matters: Oxford and AstraZeneca have said the vaccine was 90% effective in people who got a half dose followed by a full dose, and 62% effective in people who got two full doses. AstraZeneca has since acknowledged that the smaller dose received by some participants was the result of an error by a contractor, per the New York Times.

Court rejects Trump campaign's appeal in Pennsylvania case

Photo: Sarah Silbiger for The Washington Post via Getty Images

A federal appeals court on Friday unanimously rejected the Trump campaign's emergency appeal seeking to file a new lawsuit against Pennsylvania's election results, writing in a blistering ruling that the campaign's "claims have no merit."

Why it matters: It's another devastating blow to President Trump's sinking efforts to overturn the results of the election. Pennsylvania, which President-elect Joe Biden won by more than 80,000 votes, certified its results last week and is expected to award 20 electoral votes to Biden on Dec. 12.

Dave Lawler, author of World
3 hours ago - World

Belarus dictator Lukashenko says he'll leave post after new constitution

Photo: Valery Sharifulin\TASS via Getty

Longtime Belarusian President Aleksandr Lukashenko has said he will step down after a new constitution comes into force, according to Belarusian state media.

Why it matters: Lukashenko has faced three months of protests following a rigged election in August. He has promised to reform the constitution to reduce the near-absolute powers of the president, but has insisted that his strong hand is needed to see that process through.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!